Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany.
- DOI
- 10.3389/fphar.2025.1699906
- Published
- 2026-01-26
- Container
- Front Pharmacol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2025.1699906,
title = {Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany.},
author = {Schultz-Heienbrok R and Baumann S and Böhm R and Bonertz A and Breithaupt-Groegler K and Buckpesch-Heberer U and Coenen M and Erb-Zohar K and Faisst N and Grass G and Höchel J and Kovar A and Muehlenbroich A and Rengelshausen J and Riedel C and Schug B and Sudhop T and Warnke A and Ziegele B.},
year = {2025},
journal = {Front Pharmacol},
doi = {10.3389/fphar.2025.1699906},
url = {https://doi.org/10.3389/fphar.2025.1699906}
}RIS
TY - JOUR TI - Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany. AU - Schultz-Heienbrok R AU - Baumann S AU - Böhm R AU - Bonertz A AU - Breithaupt-Groegler K AU - Buckpesch-Heberer U AU - Coenen M AU - Erb-Zohar K AU - Faisst N AU - Grass G AU - Höchel J AU - Kovar A AU - Muehlenbroich A AU - Rengelshausen J AU - Riedel C AU - Schug B AU - Sudhop T AU - Warnke A AU - Ziegele B. PY - 2025 JO - Front Pharmacol DO - 10.3389/fphar.2025.1699906 UR - https://doi.org/10.3389/fphar.2025.1699906 ER -
APA
R, S., S, B., R, B., A, B., K, B., U, B., M, C., K, E., N, F., G, G., J, H., A, K., A, M., J, R., C, R., B, S., T, S., A, W., & B., Z. (2025). Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany.. Front Pharmacol. https://doi.org/10.3389/fphar.2025.1699906
Source records
- europe-pmc · retrieved 2026-09-26T17:56:27.980Z
- doaj · retrieved 2026-09-26T17:56:27.976Z